Werewolf Therapeutics Announces Publication of Data Demonstrating the Preclinical Efficacy of WTX-124 in Delivering IL-2 Selectively to the Tumor Microenvironment Globe Newswire: March 16, 2022 Read More
Go back to Press Page
